Access content directly

Didier Blaise

Researcher identifiers



Mechanisms of NK cell dysfunction in the tumor microenvironment and current clinical approaches to harness NK cell potential for immunotherapy

Raynier Devillier , Anne‐sophie Chrétien , Thomas Pagliardini , Nassim Salem , Didier Blaise et al.
Journal of Leukocyte Biology, 2021, 109 (6), pp.1071-1088. ⟨10.1002/JLB.5MR0920-198RR⟩
Journal articles hal-03623194v1
Image document

Post-transplant cyclophosphamide for graft-versus-host disease prophylaxis in HLA matched sibling or matched unrelated donor transplant for patients with acute leukemia, on behalf of ALWP-EBMT

Annalisa Ruggeri , Myriam Labopin , Andrea Bacigalupo , Boris Afanasyev , Jan J Cornelissen et al.
Journal of Hematology and Oncology, 2018, 11, pp.40. ⟨10.1186/s13045-018-0586-4⟩
Journal articles hal-01762520v1
Image document

NKp46 expression on NK cells as a prognostic and predictive biomarker for response to allo-SCT in patients with AML

Anne-Sophie Chrétien , Raynier Devillier , Cyril Fauriat , Florence Orlanducci , Samia Harbi et al.
OncoImmunology, 2017, 6 (12), pp.e1307491. ⟨10.1080/2162402X.2017.1307491⟩
Journal articles hal-01789566v1

Rituximab-based first-line treatment of cGVHD after allogeneic SCT: results of a phase 2 study

Florent Malard , Myriam Labopin , Ibrahim Yakoub-Agha , Sylvain Chantepie , Thierry Guillaume et al.
Blood, 2017, 130 (20), pp.2186-2195. ⟨10.1182/blood-2017-05-786137⟩
Journal articles inserm-02155352v1

Clofarabine versus fludarabine-based reduced-intensity conditioning regimen prior to allogeneic transplantation in adults with AML/MDS

Patrice Chevallier , Marie Labopin , Régis Peffault de La Tour , Bruno Lioure , Claude-Eric Bulabois et al.
Cancer Medicine, 2016, 5 (11), pp.3068 - 3076. ⟨10.1002/cam4.880⟩
Journal articles hal-01818593v1
Image document

Single- or double-unit UCBT following RIC in adults with AL: a report from Eurocord, the ALWP and the CTIWP of the EBMT

Frédéric Baron , Annalisa Ruggeri , Eric Beohou , Myriam Labopin , Mohamad Mohty et al.
Journal of Hematology and Oncology, 2016, 10 (1), pp.128. ⟨10.1186/s13045-017-0497-9⟩
Journal articles inserm-01546618v1

Impact of in vivo T cell depletion in HLA-identical allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission conditioned with a fludarabine iv-busulfan myeloablative regimen: a report from the EBMT Acute Leukemia Working Party

Marie Thérèse Rubio , Maud D’aveni-Piney , Myriam Labopin , Rose-Marie Hamladji , Miguel A. Sanz et al.
Journal of Hematology and Oncology, 2016, 10 (1), pp.31. ⟨10.1186/s13045-016-0389-4⟩
Journal articles inserm-01444368v1
Image document

Low non-relapse mortality and long-term preserved quality of life in older patients undergoing matched related donor allogeneic stem cell transplantation: a prospective multicenter phase II trial

Didier Blaise , Raynier Devillier , Anne-Gaelle Lecoroller-Sorriano , Jean-Marie Boher , Agnès Boyer-Chammard et al.
Haematologica, 2015, 100 (2), pp.269-274. ⟨10.3324/haematol.2014.113571⟩
Journal articles hal-02167058v1

Evaluation économétrique du coût d'une allogreffe de moelle osseuse

Christel Protière , G, Tonnaire , Didier Blaise , Dominique Maraninchi , Moatti Jean-Paul et al.
Journal d'Economie Médicale, 1996, 14 (6), pp.323-331
Journal articles inserm-03199671v1